Articles and Position Papers

This section features articles and position papers published by the International Osteoporosis Foundation’s Committee of Scientific Advisors and Working Groups. These publications are arranged by topics, and an external link or pdf is provided.  

Content

*Download complete list of IOF publications as PDF: in topical sections / in order of date

Bone Markers

Johansson H,  Odén A1, Kanis JA, McCloskey EV, Morris HA, Cooper C, Vasikaran S and the IFCC-IOF Joint Working Group on standardisation of biochemical markers of bone turnover. A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int. DOI 10.1007/s00223-014-9842-y

Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA; IOF-IFCC Bone Marker Standards Working Group. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011;22(2):391-420.

Also available: Bone turnover markers educational slide kit

Vasikaran SD, Morris HA, Cooper C, Kanis JA. Standardising biochemical assessment of bone turnover in osteoporosis. Clin Biochem 2011;44(13):1033-4.

Vasikaran SD, Cooper C, Kanis JA. Recommendations for bone marker standards in osteoporosis: what, why and where to now? Ann Clin Biochem 2011;48(Pt 2):91-2. 
 
Vasikaran S, Cooper C, Eastell R, Griesmacher A, Morris HA, Trenti T, Kanis JA. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis. Clin Chem Lab Med 2011;49(8):1271-4.

Delmas PD; for the Committee of Scientific Advisors of the International Osteoporosis Foundation. Bone marker nomenclature. Bone 2001;28(6):575-6.

Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000;11(Suppl 6):S2-17.

Epidemiology / Burden

Kanis JA, Adachi JD, Cooper C, Clark P, Cummings S.R., Diaz-Curiel M, Harvey N, Hiligsmann M, Papaoiannou A, Pierroz DD, Silverman SL, Szulc P. The Epidemiology and Quality of Life Workng Group of IOF. Standardizing the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF Osteoporos Int 2013 24 (11):2763-64.

Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA; A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden Arch Osteoporos 2013 8:136.

Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA; EU review panel of the IOF. Osteoporosis in the European Union: A compendium of country-specific reports. Arch Osteoporos 2013: 8:137.

Kanis JA, Borgström F, Compston J. et al. SCOPE: A Scorecard for Osteoporosis in Europe. Arch Osteoporosis 2013 18:144. 
View one-page Scorecard here.

Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C; IOF Working Group on Epidemiology and Quality of Life. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 2012;23(9):2239-56.

Cawston H, Maravic M, Fardellone P, Gauthier A, Kanis JA, Compston J, Borgstrom F, Cooper C, McCloskey E. Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model. Arch Osteoporos 2012;7(1-2):237-46.

Strom O, Borgstrom F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jonsson B. Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 2011;6(1-2):59-155.

Gauthier A, Kanis JA, Jiang Y, Martin M, Compston JE, Borgstrom F, Cooper C, McCloskey EV. Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model. Arch Osteoporos 2011;6(1-2):179-88.

Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA; IOF CSA Working Group on Fracture Epidemiology. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 2011;22(5):1277-88.

Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;7(5):407-13.

Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17(12):1726-33.

Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK. The components of excess mortality after hip fracture. Bone 2003;32(5):468-73.

FRAX / Technical Report / Risk

Kanis J.A, Johansson H, Oden A, Cooper C, McCloskey E. V. and the Epidemiology and Quality of Life Working Group of IOF  Worldwide Uptake of FRAX. Arch Osteoporos 2014; 8:166

Wu C, McCloskey EV, Kiong Lee J, et al. on behalf of the Asia Pacific Panel of ISCD; Consensus of Official Position of IOF/ISCD FRAX Initiatives in Asia-Pacific Region.J Clin Densitom. 2013 Jul 31. doi: 10.1016/j.jocd.2013.06.002. Epub ahead of print

McCloskey EV, Vasikaran S, Cooper C; FRAX® Position Development Conference Members. Official Positions for FRAX® Clinical Regarding Biochemical Markers. J Clin Densitom 2011;14(3):220-2.

McCloskey EV, Binkley N; FRAX® Position Development Conference Members. FRAX® Clinical Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference. J Clin Densitom 2011;14(3):181-3.

Masud T, Binkley N, Boonen S, Hannan MT; FRAX® Position Development Conference Members. Official Positions for FRAX® Clinical Regarding Falls and Frailty: Can Falls and Frailty be Used in FRAX®? J Clin Densitom 2011;14(3):194-204.

Lewiecki EM, Compston JE, Miller PD, Adachi JD, Adams JE, Leslie WD, Kanis JA, Moayyeri A, Adler RA, Hans DB, Kendler DL, Diez-Perez A, Krieg M-A, Masri BK, Lorenc RR, Bauer DC, Blake GM, Josse RG, Clark P, Khan AA; FRAX® Position Development Conference Members. Official Positions for FRAX® Bone Mineral Density and FRAX® Simplification. J Clin Densitom 2011;14(3):226-36.

Lewiecki EM, Compston JE, Miller PD, Adachi JD, Adams JE, Leslie WD, Kanis JA; FRAX® Position Development Conference Members. FRAX® Bone Mineral Density Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference. J Clin Densitom 2011;14(3):223-5.

Leib ES, Saag KG, Adachi JD, Geusens PP, Binkley N, McCloskey EV, Hans DB; FRAX® Position Development Conference Members. Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture. J Clin Densitom 2011;14(3):212-9.

Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, Fuleihan GE-H, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV; Task Force of the FRAX Initiative. Interpretation and use of FRAX in clinical practice. Osteoporos Int 2011;22(9):2395-411.

Hans DB, Kanis JA, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Cooper C, Dawson-Hughes B, Fuleihan GE-H, Leslie WD, Lewiecki EM, Luckey MM, McCloskey EV, Papapoulos SE, Poiana C, Rizzoli R; FRAX® Position Development Conference Members. Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice. J Clin Densitom 2011;14(3):171-80.

Dimai HP, Chandran M, Members FPDC; FRAX® Position Development Conference Members. Official Positions for FRAX® Clinical Regarding Smoking. J Clin Densitom 2011;14(3):190-3. http://www.clinicaldensitometry.com/article/S1094-6950%2811%2900123-5/abstract

Cauley JA, Fuleihan GE-H, Luckey MM; FRAX® Position Development Conference Members. FRAX® International Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference. J Clin Densitom 2011;14(3):237-9.

Cauley JA, Fuleihan GE-H, Arabi A, Fujiwara S, Ragi-Eis S, Calderon A, Chionh SB, Chen Z, Curtis JR, Danielson ME, Hanley DA, Kroger H, Kung AWC, Lesnyak O, Nieves J, Pluskiewicz W, El Rassi R, Silverman S, Schott A-M, Rizzoli R, Luckey M; FRAX® Position Development Conference Members. Official Positions for FRAX® Clinical Regarding International Differences. J Clin Densitom 2011;14(3):240-62.

Broy SB, Tanner SB; FRAX® Position Development Conference Members. Official Positions for FRAX® Clinical Regarding Rheumatoid Arthritis. J Clin Densitom 2011;14(3):184-9.

Blank RD; FRAX® Position Development Conference Members. Official Positions for FRAX® Clinical Regarding Prior Fractures. J Clin Densitom 2011;14(3):205-11.

Siris E, Delmas PD. Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application. Osteoporos Int 2008;19(4):383-4.

Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group. Case finding for the management of osteoporosis with FRAX® - assessment and intervention thresholds for the UK. Osteoporos Int 2008;19(10):1395-408.

Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19(4):385-97.

Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glueer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ, III, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007;18(8):1033-46.

Kanis J; on behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level. Technical Report WHO Collaborating Centre, University of Sheffield, Sheffield. 2007.  

Johnell O, Borgstrom F, Jonsson B, Kanis J. Latitude, socioeconomic prosperity, mobile phones and hip fracture risk. Osteoporos Int 2007;18(3):333-7. http://link.springer.com/article/10.1007%2Fs00198-006-0245-4

De Laet C, Oden A, Johansson H, Johnell O, Jonsson B, Kanis JA. The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 2005;16(3):313-8.

De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ, Meunier PJ, Pols HAP, Reeve J, Silman A, Tenenhouse A. Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporos Int 2005;16(11):1330-8.

Kaptoge S, Armbrecht G, Felsenberg D, Lunt M, Weber K, Boonen S, Jajic I, Stepan JJ, Banzer D, Reisinger W, Janott J, Kragl G, Scheidt-Nave C, Felsch B, Matthis C, Raspe HH, Lyritis G, Poor G, Nuti R, Miazgowski T, Hoszowski K, Armas JB, Vaz AL, Benevolenskaya LI, Masaryk P, Cannata JB, Johnell O, Reid DM, Bhalla A, Woolf AD, Todd CJ, Cooper C, Eastell R, Kanis JA, O'Neill TW, Silman AJ, Reeve J. Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int 2006;17(9):1369-81.

Kanis JA, Johnell O, Oden A, Johansson H, Eisman JA, Fujiwara S, Kroger H, Honkanen R, Melton LJ, O'Neill T, Reeve J, Silman A, Tenenhouse A. The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int 2006;17(4):527-34.

Kanis JA, Johansson H, Oden A, De Laet C, Johnell O, Eisman JA, Mc Closkey E, Mellstrom D, Pols H, Reeve J, Silman A, Tenenhouse A. A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int 2005;16(7):799-804.

Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A. Alcohol intake as a risk factor for fracture. Osteoporos Int 2005;16(7):737-42.

Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N. Assessment of fracture risk. Osteoporos Int 2005;16(6):581-9.

Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004;35(2):375-82.

Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton LJ, Tenenhouse A, Reeve J, Silman AJ, Pols HAP, Eisman JA, McCloskey EV, Mellstrom D. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004;19(6):893-9.

Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA, McCloskey EV, Mellstrom D, Melton LJ, Pols HAP, Reeve J, Silman AJ, Tenenhouse A. A family history of fracture and fracture risk: a meta-analysis. Bone 2004;35(5):1029-37.

Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B. Mortality after osteoporotic fractures. Osteoporos Int 2004;15(1):38-42.

Johansson H, Oden A, Johnell O, Jonsson B, de Laet C, Oglesby A, McCloskey EV, Kayan K, Jalava T, Kanis JA. Optimization of BMD measurements to identify high risk groups for treatment - A test analysis. J Bone Miner Res 2004;19(6):906-13.

Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: Implications for risk assessment. J Bone Miner Res 2002;17(7):1237-44.

Johansson H, Clark P, Carlos F, Oden A, McCloskey EV, Kanis JA. Increasing age- and sex-specific rates of hip fracture in Mexico: a survey of the Mexican institute of social security. Osteoporos Int 2011;22(8):2359-64.

Kanis J, Johnell O, Gullberg B, Allander E, Elffors L, Ranstam J, Dequeker J, Dilsen G, Gennari C, Vaz AL, Lyritis G, Mazzuoli G, Miravet L, Passeri M, Cano RP, Rapado A, Ribot C. Risk factors for hip fracture in men from Southern Europe: The MEDOS study. Osteoporos Int 1999;9(1):45-54.

Health Economics / Models

Borgstrom F, Lekander I, Ivergard M, Strom O, Svedbom A, Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP, Jurisson M, Kallikorm R, Lesnyak O, McCloskey E, Nassonov E, Sanders KM, Silverman S, Tamulaitiene M, Thomas T, Tosteson ANA, Jonsson B, Kanis JA. The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS) - quality of life during the first 4 months after fracture. Osteoporos Int 2013;24(3):811-23.

Gauthier A, Kanis JA, Martin M, Compston J, Borgstrom F, Cooper C, McCloskey E; Committee of Scientific Advisors, International Osteoporosis Foundation. Development and validation of a disease model for postmenopausal osteoporosis. Osteoporos Int 2011;22(3):771-80.

Zethraeus N, Strom O, Borgstrom F, Kanis JA, Jonsson B. The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden. Osteoporos Int 2008;19(6):819-27.

Zethraeus N, Borgstrom F, Strom O, Kanis JA, Jonsson B. Cost-effectiveness of the treatment and prevention of osteoporosis - a review of the literature and a reference model. Osteoporos Int 2007;18(1):9-23.

Zethraeus N, Ben Sedrine W, Caulin F, Corcaud S, Gathon HJ, Haim M, Johnell O, Jonsson B, Kanis JA, Tsouderos Y, Reginster JY. Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis. Osteoporos Int 2002;13(11):841-57.

Kanis JA, Jonsson B. Economic evaluation of interventions for osteoporosis. Osteoporos Int 2002;13(10):765-7.

Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd Jones M. Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 2002;6(29):1-146.

Brazier JE, Green C, Kanis JA, Comm Sci A. A systematic review of health state utility values for osteoporosis-related conditions. Osteoporos Int 2002;13(10):768-76.

Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A. The burden of osteoporotic fractures: A method for setting intervention thresholds. Osteoporos Int 2001;12(5):417-27.

Nutrition  (Vitamin D / Calcium)

Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P, Hoffman K.
A systematic review of vitamin D status in populations worldwide
. Br J Nutr 2013 [Epub ahead of print DOI: 10.1017/s0007114513001840].

Mithal A, Bonjour JP, Boonen S, Burckhardt P, Degens H, El Hajj Fuleihan G, Josse R, Lips P, Morales Torres J, Rizzoli R, Yoshimura N, Wahl DA, Cooper C, Dawson-Hughes B; for the IOF CSA Nutrition Working Group. Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int 2013:[Epub ahead of print DOI: 10.1007/s00198-012-2236-y].

IOF comments on US Task Force recommendations regarding vitamin D and calcium supplementation. 2013.

Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, Hoffmann K, Josse R, Kanis JA, Mithal A, Pierroz DD, Stenmark J, Stocklin E, Dawson-Hughes B. A global representation of vitamin D status in healthy populations. Arch Osteoporos 2012;7(1-2):155-72.

IOF response to study linking calcium supplements to increased risk of heart attacks. 2012.

Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GEH, Josse RG, Lips P, Morales-Torres J, Yoshimura N. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010;21(7):1151-4.

Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, Fuleihan GE-H, Josse RG, Lips P, Morales-Torres J; IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009;20(11):1807-20.

Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY. The role of calcium and vitamin D in the management of osteoporosis. Bone 2008;42(2):246-9.

IOF comment on The Women’s Health Initiative (WHI) calcium plus vitamin D supplementation trial. 2006.

Boonen S, Rizzoli R, Meunier PJ, Stone M, Nuki G, Syversen U, Lehtonen-Veromaa M, Lips P, Johnell O, Reginster JY. The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int 2004;15(7):511-9.

Quality of Life

Jörg Goldhahn, Dorcas Beaton, Amy Ladd, Joy Macdermid, Amy Hoang-Kim.  On behalf of the Distal Radius Working Group of ISFR and IOF Recommendation for measuring clinical outcome in distal radius fractures: a core set of domains for standardized reporting in clinical practice and research. Arch Orthop Trauma Surg. DOI 10.1007/s00402-013-1767-9

Murell P, Todd CJ, Martin A, Walton J, Lips P, Reeve J; Working Party for Quality of Life of the International Osteoporosis Foundation. Postal administration compared with of the QUALEFFO-41 in a population and assessment nurse-supported administration sample: Comparison of results of psychometric properties. Osteoporos Int 2001;12(8):672-9.

Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, Kanis J. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 2000;15(7):1384-92.

Lips P, Jameson K, Bianchi ML, Goemaere S, Boonen S, Reeve J, Stepan J, Johnell O, van Schoor NM, Dennison E, Kanis JA, Cooper C; Working Group for Quality of Life of the International Osteoporosis Foundation. Validation of the IOF quality of life questionnaire for patients with wrist fracture. Osteoporos Int 2010;21(1):61-70.

Secondary Fracture Prevention / Coordinator-Based Systems

Akesson K, Marsh D, Mitchell P, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C; IOF Fracture Working Group. Capture the Fracture: A Best Practice Framework and Global Campaign to Break the Fragility Fracture Cycle. Osteoporos Int 2013:[in press].

Mitchell PJ. Best practices in secondary fracture prevention: fracture liaison services. Curr Osteoporos Rep 2013;11(1):52-60.

Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML, McLellan AR, Mitchell PJ, Sale JEM, Wahl DA; IOF CSA Fracture Working Group. Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 2011;22(7):2051-65.

Cooper C, Mitchell P, Kanis JA. Breaking the fragility fracture cycle. Osteoporos Int 2011;22(7):2049-50.

Bouxsein ML, Kaufman J, Tosi L, Cummings S, Lane J, Johnell O. Recommendations for optimal care of the fragility fracture patient to reduce the risk of future fracture. J Am Acad Orthop Surg 2004;12(6):385-95.

Johnell O, Kaufman JM, Cummings SR, Lane J, Bouxsein M; WOOO, BJD, EFORT and IOF. Recommendations for Care of the Osteoporotic Fracture Patient to Reduce the Risk of Future Fracture. 2002.

Dreinhoefer KE, Anderson M, Feron J-M, Herrera A, Hube R, Johnell O, Lidgren L, Miles K, Tarantino U, Simpson H, Wallace WA. Multinational survey of osteoporotic fracture management. Osteoporos Int 2005;16(Suppl 2):S44-53.

Dreinhofer KE, Feron JM, Herrera A, Hube R, Johnell O, Lidgren L, Miles K, Panarella L, Simpson H, Wallace WA. Orthopaedic surgeons and fragility fractures - A survey by the Bone and Joint Decade and the International Osteoporosis Foundation. J Bone Joint Surg Br 2004;86B(7):958-61. 
 
Compston J. Action Plan for the prevention of osteoporotic fractures in the European Community. Osteoporos Int 2004;15(4):259-62.

Survey Findings / IOF Statements / Calls to Action

Rizzoli R, Brandi ML, Dreinhoefer KE, Thomas T, Wahl D, Cooper C. The gaps between patient and physician understanding of the emotional and physical impact of osteoporosis. Arch Osteoporos 2010;5(1-2):145-53.

Cooper C, Rizzoli R, Reginster JY. The International Osteoporosis Foundation: history, objectives and achievements. Osteoporos Int 2009;20(Suppl 3):S241-2.

Czerwinski E, Badurski JE, Marcinowska-Suchowierska E, Osieleniec J. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation. Ortop Traumatol Rehabil 2007;9(4):337-56.

Kanis JA, Seeman E, Johnell O, Rizzoli R, Delmas P. The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry. J Clin Densitom 2005;8(2):145-7.

Delmas PD, Rizzoli R, Cooper C, Reginster JY. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int 2005;16(1):1-5.

European Action Towards Better Musculoskeletal Health: A Public Health Strategy to Reduce the Burden of Musculoskeletal Conditions; From the European Bone and Joint Health Strategies Project (BJD, EULAR, EFORT and IOF). 2004.

Delmas PD, Fraser M. Strong bones in later life: luxury or necessity? Bull World Health Organ 1999;77(5):416-22.

Treatment & Management / Guidelines

Kanis JA, McCloskey E, Branco J, Brandi M-L, Dennison E, Devogelaer J-P, Ferrari S, Kaufman J-M, Papapoulos S, Reginster J-Y, Rizzoli R for the Committee of Scientific Advisors of the International Osteoporosis Foundation and the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. Goal-directed treatment of osteoporosis in Europe. Osteoporos Int 2014 25:2533-2543. DOI 10.1007/s00198-014-2787-1

Rizzoli R, Body JJ, Brandi M.-L. Brandi et al. for the International Osteoporosis
Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease (2013) Cancer-associated bone disease.
Osteoporos Int 2013 DOI 10.1007/s00198-013-2530-3

Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013;24(1):23-57.

Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgstrom F, Cooper C, Perez AD, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE; Joint IOF–ECTS GIO Guidelines Working Group. An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. Arch Osteoporos 2012;7(1-2):25-30.

Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgstrom F, Cooper C, Diez Perez A, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE; Joint IOF-ECTS GIO Guidelines Working Group. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 2012;23(9):2257-76.

Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA, Stepan JJ, de Vernejoul MC, Kaufman JM; IOF Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology. Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 2012;23(12):2735-48.

Diez-Perez A, Adachi JD, Agnusdei D, Bilezikian JP, Compston JE, Cummings SR, Eastell R, Eriksen EF, Gonzalez-Macias J, Liberman UA, Wahl DA, Seeman E, Kanis JA, Cooper C; IOF CSA Inadequate Responders Working Group. Treatment failure in osteoporosis. Osteoporos Int 2012;23(12):2769-74.

Cooper C, Reginster JY, Cortet B, Diaz-Curiel M, Lorenc RS, Kanis JA, Rizzoli R. Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Curr Med Res Opin 2012;28(3):475-91.

Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, Sieber CC, Kaufman JM, Abellan van Kan G, Boonen S, Adachi J, Mitlak B, Tsouderos Y, Rolland Y, Reginster JYL. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 2012;23(7):1839-48.

Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster JY, Cooper C. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int 2011;22(2):373-90.

Kanis JA, Bianchi G, Bilezikian JP, Kaufman JM, Khosla S, Orwoll E, Seeman E; on behalf of the Committee of Scientific Advisors of the International Osteoporosis Foundation. Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int 2011;22(11):2789-98.

Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R; European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19(4):399-428.

Kanis JA, Johnell O. Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 2005;16(3):229-38.

Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, Delmas P, Eisman J, Johnell O, Jonsson B, Melton L, Oden A, Papapoulos S, Pols H, Rizzoli R, Silman A, Tenenhouse A; International Osteoporosis Foundation; National Osteoporosis Foundation. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 2002;13(7):527-36.

Kanis JA, Torgerson D, Cooper C. Comparison of the European and USA practice guidelines for osteoporosis. Trends Endocrinol Metab 2000;11(1):28-32.

Kanis JA, Gluer CC; Committee of Scientific Advisors, International Osteoporosis Foundation. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 2000;11(3):192-202.

Guidelines for preclinical evaluation and clinical trials in osteoporosis. WHO, Geneva. 1998.

Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 1997;7(4):390-406.

Gluer CC; The International Quantitative Ultrasound Consensus Group. Quantitative ultrasound techniques for the assessment of osteoporosis: Expert agreement on current status. J Bone Miner Res 1997;12(8):1280-8.

Kanis JA, Devogelaer JP, Gennari C; The Scientific Advisory Board and the Board of National Societies of the European Foundation for Osteoporosis and Bone Disease. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: A position paper of the European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 1996;6(3):256-61.

Kanis JA, Geusens P, Christiansen C. Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 1991;1(3):182-8.

Consensus development conference: prophylaxis and treatment of osteoporosis. Osteoporos Int 1991;1(2):114-7.

Vertebral Fractures

Boonen S, Wahl DA, Nauroy L, Brandi ML, Bouxsein ML, Goldhahn J, Lewiecki EM, Lyritis GP, Marsh D, Obrant K, Silverman S, Siris E, Akesson K; CSA Fracture Working Group of International Osteoporosis Foundation. Balloon kyphoplasty and vertebroplasty in the management of vertebral compression fractures. Osteoporos Int 2011;22(12):2915-34. 

Clark P, Cons-Molina F, Deleze M, Ragi S, Haddock L, Zanchetta JR, Jaller JJ, Palermo L, Talavera JO, Messina DO, Morales-Torres J, Salmeron J, Navarrete A, Suarez E, Perez CM, Cummings SR. The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int 2009;20(2):275-82. 

Oleksik AM, Ewing S, Shen W, van Schoor NM, Lips P. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporos Int 2005;16(8):861-70. 

Lenchik L, Rogers LF, Delmas PD, Genant HK. Diagnosis of osteoporotic vertebral fractures: Importance of recognition and description by radiologists. Am J Roentgenol 2004;183(4):949-58. 

Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B. Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 2004;15(2):108-12. 

Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B. The risk and burden of vertebral fractures in Sweden. Osteoporos Int 2004;15(1):20-6. 

Cockerill W, Lunt M, Silman AJ, Cooper C, Lips P, Bhalla AK, Cannata JB, Eastell R, Felsenberg D, Gennari C, Johnell O, Kanis JA, Kiss C, Masaryk P, Naves M, Poor G, Raspe H, Reid DM, Reeve J, Stepan J, Todd C, Woolf AD, O'Neill TW. Health-related quality of life and radiographic vertebral fracture. Osteoporos Int 2004;15(2):113-9. 

Grigoryan M, Guermazi A, Roemer FW, Delmas PD, Genant HK. Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J 2003;12(Suppl 2):S104-S12. 

Lunt M, Ismail AA, Felsenberg D, Cooper C, Kanis JA, Reeve J, Silman AJ, O'Neill TW; European Prospective Osteoporosis Study Group. Defining incident vertebral deformities in population studies: A comparison of morphometric criteria. Osteoporos Int 2002;13(10):809-15. 

Felsenberg D, Silman AJ, Lunt M, Armbrecht G, Ismail AA, Finn JD, Cockerill WC, Banzer D, Benevolenskaya LI, Bhalla A, Bruges AJ, Cannata JB, Cooper C, Dequeker J, Eastell R, Felsch B, Gowin W, Havelka S, Hoszowski K, Jajic I, Janott J, Johnell O, Kanis JA, Kragl G, Lopes VA, Lorenc R, Lyritis G, Masaryk P, Matthis C, Miazgowski T, Parisi G, Poor G, Raspe HH, Reid DM, Reisinger W, Scheidt-Nave C, Stepan JJ, Todd CJ, Weber K, Woolf AD, Yershova OB, Reeve J, O'Neill TW; European Prospective Osteoporosis Study (EPOS) Group. Incidence of vertebral fracture in Europe: Results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002;17(4):716-24. 

Ismail AA, Cockerill W, Cooper C, Finn JD, Abendroth K, Parisi G, Banzer D, Benevolenskaya LI, Bhalla AK, Armas JB, Cannata JB, Delmas PD, Dequeker J, Dilsen G, Eastell R, Ershova O, Falch JA, Felsch B, Havelka S, Hoszowski K, Jajic I, Kragl U, Johnell O, Vaz AL, Lorenc R, Lyritis G, Marchand F, Masaryk P, Matthis C, Miazgowski T, Pols HAP, Poor G, Rapado A, Raspe HH, Reid DM, Reisinger W, Janott J, Scheidt-Nave C, Stepan J, Todd C, Weber K, Woolf AD, Ambrecht G, Gowin W, Felsenberg D, Lunt M, Kanis JA, Reeve J, Silman AJ, O'Neill TW. Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: Results from the European Prospective Osteoporosis Study. Osteoporos Int 2001;12(2):85-90. 

O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ, Agnusdei D, Bergmann K, Dequeker J, Kruskemper G, Raspe H, Marsden D, Wieland E, Kalidis L, Mews J, Lauermann T, Weber K, Geusens P, Jajic I, Havelka S, Vavrincova P, Delmas PD, Marchand F, Banzer D, Kirschner S, Reisinger W, Janott J, Schatz H, Franke J, ScheidtNave C, Ziegler R, Abendroth K, Felsch B, Matthis C, Antoniou A, Lyritis G, Kiss C, Poor G, Gennari C, Ortolani S, Hofman A, Pols HAP, Falch JA, Meyer HE, Czekalski S, Miazgowski T, Hoszowski K, Lorenc RS, Aroso A, Vaz AL, Benevolenskaya LI, Mikhailov EE, Letkovska A, Masaryk P, Escofet DR, Martin MR, Sosa M, Curiel MD, Rapado A, Andia JBC, Lopez JBD, Johnell O, Nilsson B, Dilsen G, Reid DM, Bhalla AK, Ring F, Todd C, Williams R, Reeve J, Eastell R, Woolf AD. The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study. J Bone Miner Res 1996;11(7):1010-8. 

Oneill TW, Marsden D, Silman AJ. Differences in the characteristics of responders and non-responders in a prevalence survey of vertebral osteoporosis. Osteoporos Int 1995;5(5):327-34. 

O'Neill TW, Varlow J, Felsenberg D, Johnell O, Weber K, Marchant F, Delmas PD, Cooper C, Kanis J, Silman AJ, Agnusdei D, Dequeker J, Kruskemper G, Raspe H, Bergmann K. Variation in vertebral height ratios in population studies. J Bone Miner Res 1994;9(12):1895-907.